Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
BNN-20, a synthetic microneurotrophin, strongly protects dopaminergic neurons in the "weaver" mouse, a genetic model of dopamine-denervation, acting through the TrkB neurotrophin receptor.
Botsakis K, Mourtzi T, Panagiotakopoulou V, Vreka M, Stathopoulos GT, Pediaditakis I, Charalampopoulos I, Gravanis A, Delis F, Antoniou K, Zisimopoulos D, Georgiou CD, Panagopoulos NT, Matsokis N, Angelatou F. Botsakis K, et al. Among authors: delis f. Neuropharmacology. 2017 Jul 15;121:140-157. doi: 10.1016/j.neuropharm.2017.04.043. Epub 2017 Apr 28. Neuropharmacology. 2017. PMID: 28461162
Anti-neuroinflammatory, protective effects of the synthetic microneurotrophin BNN-20 in the advanced dopaminergic neurodegeneration of "weaver" mice.
Panagiotakopoulou V, Botsakis K, Delis F, Mourtzi T, Tzatzarakis MN, Dimopoulou A, Poulia N, Antoniou K, Stathopoulos GT, Matsokis N, Charalampopoulos I, Gravanis A, Angelatou F. Panagiotakopoulou V, et al. Among authors: delis f. Neuropharmacology. 2020 Mar 15;165:107919. doi: 10.1016/j.neuropharm.2019.107919. Epub 2019 Dec 23. Neuropharmacology. 2020. PMID: 31877321
Psychoactive properties of BNN27, a novel neurosteroid derivate, in male and female rats.
Kokras N, Dioli C, Paravatou R, Sotiropoulos MG, Delis F, Antoniou K, Calogeropoulou T, Charalampopoulos I, Gravanis A, Dalla C. Kokras N, et al. Among authors: delis f. Psychopharmacology (Berl). 2020 Aug;237(8):2435-2449. doi: 10.1007/s00213-020-05545-5. Epub 2020 Jun 7. Psychopharmacology (Berl). 2020. PMID: 32506234
The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
Gueye AB, Pryslawsky Y, Trigo JM, Poulia N, Delis F, Antoniou K, Loureiro M, Laviolette SR, Vemuri K, Makriyannis A, Le Foll B. Gueye AB, et al. Among authors: delis f. Int J Neuropsychopharmacol. 2016 Dec 30;19(12):pyw068. doi: 10.1093/ijnp/pyw068. Print 2016 Dec. Int J Neuropsychopharmacol. 2016. PMID: 27493155 Free PMC article.
37 results